Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 21, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 6OKP | B3UES2 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | S6B291 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | 6OKP | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | S6B291 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | 6OKP | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | Q8N5F4 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | Q8N5F4 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | P01834 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 6OKP | P01834 | B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 | Envelope glycoprotein gp41, Envelope glycoprotein gp120, 10-1074 Heavy Chain,10-1074 Light Chain, SF12 Heavy Chain,SF12 Light Chain |
| 8OWW | P0DTC2 | B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan) | |
| 8OWW | 8OWW | B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan) | |
| 8AQU | P01865 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQU | Q8R0I0 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQU | P10104 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQU | P0DTC2 | BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8WGV | P0DTC2 | BA.2(S375) Spike (S6P)/hACE2 complex | |
| 8WGV | Q9BYF1 | BA.2(S375) Spike (S6P)/hACE2 complex | |
| 8CIM | P10104 | BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN | |
| 8CIM | P0DTC2 | BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN | |
| 8CIM | 8CIM | BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN | |
| 8AQV | P01865 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQV | Q8R0I0 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQV | P10104 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQV | P0DTC2 | BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8WHZ | Q9BYF1 | BA.2.86 RBD in complex with hACE2 (local refinement) | |
| 8WHZ | P0DTC2 | BA.2.86 RBD in complex with hACE2 (local refinement) | |
| 8XUR | P0DTC2 | BA.2.86 Spike Trimer in complex with heparan sulfate | |
| 8X56 | P0DTC2 | BA.2.86 Spike Trimer with T356K mutation (1 RBD up) | |
| 8X55 | P0DTC2 | BA.2.86 Spike Trimer with T356K mutation (3 RBD down) | |
| 8X50 | P0DTC2 | BA.2.86 Spike Trimer with ins483V mutation (1 RBD up) | |
| 8X4Z | P0DTC2 | BA.2.86 Spike Trimer with ins483V mutation (3 RBD down) | |
| 8XUU | P0DTC2 | BA.2.86-T356K Spike Trimer in complex with heparan sulfate (Local refinement) | |
| 8AQS | P10104 | BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local) | |
| 8AQS | P0DTC2 | BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local) | |
| 8AQS | Q9BYF1 | BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local) | |
| 8AQW | P01863 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQW | Q8R0I0 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQW | P10104 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8AQW | P0DTC2 | BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) | |
| 8CIN | P0DTC2 | BA.4/5-5 FAB IN COMPLEX WITH SARS-COV-2 BA.4 SPIKE GLYCOPROTEIN | |
| 8CIN | 8CIN | BA.4/5-5 FAB IN COMPLEX WITH SARS-COV-2 BA.4 SPIKE GLYCOPROTEIN | |
| 1B9Z | P36924 | BACILLUS CEREUS BETA-AMYLASE COMPLEXED WITH MALTOSE | |
| 1EO7 | P43379 | BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE IN COMPLEX WITH MALTOHEXAOSE | |
| 1DTU | P43379 | BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE: A MUTANT Y89D/S146P COMPLEXED TO AN HEXASACCHARIDE INHIBITOR | |
| 1QBB | Q54468 | BACTERIAL CHITOBIASE COMPLEXED WITH CHITOBIOSE (DINAG) | |
| 1D9U | P03706 | BACTERIOPHAGE LAMBDA LYSOZYME COMPLEXED WITH A CHITOHEXASACHARIDE | |
| 8HXK | A0A7D7J6S6 | BANAL-20-236 S1 in complex with R. Affinis ACE2 | |
| 8HXK | A0A7D6P0R3 | BANAL-20-236 S1 in complex with R. Affinis ACE2 | |
| 8I3W | 8I3W | BANAL-20-236 Spike trimer | |
| 8HXJ | P0DTC2 | BANAL-20-52 Spike trimer |
